Report cover image

Global Genetic Testing Market Forecast 2022-2030

Publisher Inkwood Research
Published Mar 21, 2022
Length 240 Pages
SKU # INKR17039083

Description

Global Genetic Testing Market Forecast 2022-2030

KEY FINDINGS

The global genetic testing market is set to project a CAGR of 10.25% during the forecast period, 2022-2030. The growing direct-to-consumer genetic testing, biotechnology advancements, and increasing prenatal testing drive market growth.

MARKET INSIGHTS

Genetic testing is used to determine a person’s vulnerability to developing specific diseases or disorders. The major types of genetic testing include diagnostic testing, newborn screening, and prenatal testing.

Prenatal genetic testing comprises 31.2% of all genetic tests. Genetic testing can detect pre-birth diseases. It can help detect certain types of abnormalities in a baby’s genes during pregnancy. Among these, Trisomy 18 and down syndrome are often screened for as part of prenatal genetic testing. Conventionally, it is conducted through invasive testing like amniocentesis. Also, tests like cell-free DNA testing evaluate a baby’s DNA through a blood test conducted on the mother. The growth of parental genetic testing is attributed to the fears associated with developing genetic disorders in children. Such aspects contribute to the global genetic testing market growth. However, government regulations and high treatment costs hinder the market growth.

REGIONAL INSIGHTS

The global genetic testing market growth assessment includes the geographical analysis of North America, Europe, Asia-Pacific, and Rest of World. North America is the dominating region in the global market in terms of market share. This is accredited to the well-developed healthcare infrastructure and economic growth.

COMPETITIVE INSIGHTS

With a small number of companies manufacturing complex devices, the market rivalry is intense among companies to sell products. Bio-Rad Laboratories, Abbott Laboratories, CSL Limited, BGI Group, etc., are among the leading market players.

Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

240 Pages
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Advancements In Biotechnology
3.1.2. Growth In Prenatal Testing
3.1.3. Rise In Direct-to-consumer Genetic Testing
3.1.4. Genetic Testing Helps In Determining Medication Dosage
3.2. Key Restraints
3.2.1. Expensive Cost Of Treatment
3.2.2. Government Regulation And Legislation
4. Key Analytics
4.1. Impact Of Covid-19 On Genetic Testing Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.8. Regulatory Framework
5. Market By Type
5.1. Prenatal And Newborn Testing
5.2. Diagnostic Testing
5.3. Predictive & Presymptomatic Testing
5.4. Carrier Testing
5.5. Pharmacogenomic Testing
5.6. Other Types
6. Market By Technology
6.1. Molecular Testing
6.2. Cytogenetic Testing
6.3. Biochemical Testing
7. Market By Application
7.1. Genetic Disease Diagnosis
7.2. Cancer Diagnosis
7.3. Cardiovascular Disease Diagnosis
7.4. Other Applications
8. Market By Disease
8.1. Cancer
8.2. Cystic Fibrosis
8.3. Huntington’s Disease
8.4. Sickle Cell Anaemia
8.5. Duchenne Muscular Dystrophy
8.6. Alzheimer’s Disease
8.7. Rare Diseases
8.8. Thalassemia
8.9. Other Diseases
9. Geographical Analysis
9.1. North America
9.1.1. Market Size & Estimates
9.1.2. Key Growth Enablers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. United States
9.1.5.2. Canada
9.2. Europe
9.2.1. Market Size & Estimates
9.2.2. Key Growth Enablers
9.2.3. Key Challenges
9.2.4. Key Players
9.2.5. Country Analysis
9.2.5.1. United Kingdom
9.2.5.2. Germany
9.2.5.3. France
9.2.5.4. Spain
9.2.5.5. Italy
9.2.5.6. Russia
9.2.5.7. Nordic Countries
9.2.5.8. Rest Of Europe
9.3. Asia-pacific
9.3.1. Market Size & Estimate
9.3.2. Key Growth Enablers
9.3.3. Key Challenges
9.3.4. Key Players
9.3.5. Country Analysis
9.3.5.1. China
9.3.5.2. Japan
9.3.5.3. India
9.3.5.4. South Korea
9.3.5.5. Indonesia
9.3.5.6. Australia & New Zealand
9.3.5.7. Singapore
9.3.5.8. Taiwan
9.3.5.9. Rest Of Asia-pacific
9.4. Rest Of World
9.4.1. Market Size & Estimates
9.4.2. Key Growth Enablers
9.4.3. Key Challenges
9.4.4. Key Players
9.4.5. Regional Analysis
9.4.5.1. Latin America
9.4.5.2. Middle East & Africa
10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions & Divestitures
10.2. Company Profiles
10.2.1. 23&Me Inc
10.2.2. Abbott Laboratories
10.2.3. Bgi Group
10.2.4. Biorad Laboratories
10.2.5. Csl Limited
10.2.6. Decode Genetics
10.2.7. Elitech Group
10.2.8. Eurofins Scientific
10.2.9. Illumina Inc
10.2.10. Luminex Corporation
10.2.11. Myriad Genetics Inc
10.2.12. Perkinelmer Inc
10.2.13. Qiagen
10.2.14. Quest Diagnostics Inc
10.2.15. Roche Diagnostics Inc

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us